KeyBank National Association’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.68M | Sell |
7,775
-1,059
| -12% | -$203K | 0.01% | 519 |
|
|
2026
Q1 | $1.62M | Buy |
8,834
+416
| +5% | +$76.7K | 0.01% | 494 |
|
|
2025
Q4 | $1.48M | Buy |
8,418
+164
| +2% | +$26.8K | 0.01% | 502 |
|
|
2025
Q3 | $1.16M | Buy |
8,254
+161
| +2% | +$21.8K | ﹤0.01% | 552 |
|
|
2025
Q2 | $1.02M | Buy |
8,093
+582
| +8% | +$72.5K | ﹤0.01% | 570 |
|
|
2025
Q1 | $1.03M | Sell |
7,511
-122
| -2% | -$17.4K | ﹤0.01% | 547 |
|
|
2024
Q4 | $1.17M | Sell |
7,633
-106
| -1% | -$17.9K | ﹤0.01% | 530 |
|
|
2024
Q3 | $1.5M | Sell |
7,739
-182
| -2% | -$38.1K | 0.01% | 467 |
|
|
2024
Q2 | $1.84M | Buy |
7,921
+98
| +1% | +$21.3K | 0.01% | 427 |
|
|
2024
Q1 | $1.69M | Sell |
7,823
-2,515
| -24% | -$589K | 0.01% | 432 |
|
|
2023
Q4 | $2.68M | Sell |
10,338
-782
| -7% | -$192K | 0.01% | 355 |
|
|
2023
Q3 | $2.86M | Buy |
11,120
+72
| +0.7% | +$19.3K | 0.01% | 327 |
|
|
2023
Q2 | $3.15M | Buy |
11,048
+118
| +1% | +$35.1K | 0.01% | 319 |
|
|
2023
Q1 | $3.04M | Buy |
10,930
+621
| +6% | +$172K | 0.01% | 320 |
|
|
2022
Q4 | $2.85M | Buy |
10,309
+1,635
| +19% | +$462K | 0.01% | 326 |
|
|
2022
Q3 | $2.32M | Sell |
8,674
-541
| -6% | -$115K | 0.01% | 338 |
|
|
2022
Q2 | $1.88M | Buy |
9,215
+79
| +0.9% | +$16.1K | 0.01% | 367 |
|
|
2022
Q1 | $1.92M | Sell |
9,136
-674
| -7% | -$147K | 0.01% | 380 |
|
|
2021
Q4 | $2.35M | Sell |
9,810
-718
| -7% | -$185K | 0.01% | 368 |
|
|
2021
Q3 | $2.98M | Sell |
10,528
-1,500
| -12% | -$492K | 0.01% | 323 |
|
|
2021
Q2 | $4.17M | Buy |
12,028
+1,223
| +11% | +$370K | 0.02% | 290 |
|
|
2021
Q1 | $3.02M | Sell |
10,805
-616
| -5% | -$166K | 0.01% | 314 |
|
|
2020
Q4 | $2.8M | Sell |
11,421
-1,651
| -13% | -$426K | 0.01% | 314 |
|
|
2020
Q3 | $3.71M | Sell |
13,072
-204
| -2% | -$56.9K | 0.02% | 281 |
|
|
2020
Q2 | $3.55M | Sell |
13,276
-505
| -4% | -$152K | 0.02% | 282 |
|
|
2020
Q1 | $4.36M | Sell |
13,781
-82
| -0.6% | -$24.9K | 0.03% | 251 |
|
|
2019
Q4 | $4.11M | Sell |
13,863
-709
| -5% | -$197K | 0.02% | 282 |
|
|
2019
Q3 | $3.39M | Sell |
14,572
-1,503
| -9% | -$350K | 0.02% | 294 |
|
|
2019
Q2 | $3.76M | Buy |
16,075
+223
| +1% | +$51.5K | 0.02% | 292 |
|
|
2019
Q1 | $3.75M | Sell |
15,852
-91
| -0.6% | -$28.7K | 0.02% | 282 |
|
|
2018
Q4 | $4.8M | Buy |
15,943
+73
| +0.5% | +$23.3K | 0.03% | 253 |
|
|
2018
Q3 | $5.61M | Sell |
15,870
-840
| -5% | -$289K | 0.03% | 247 |
|
|
2018
Q2 | $4.85M | Sell |
16,710
-1,244
| -7% | -$350K | 0.03% | 258 |
|
|
2018
Q1 | $4.92M | Buy |
17,954
+3,140
| +21% | +$975K | 0.03% | 260 |
|
|
2017
Q4 | $4.72M | Sell |
14,814
-676
| -4% | -$217K | 0.03% | 256 |
|
|
2017
Q3 | $4.85M | Buy |
15,490
+1,870
| +14% | +$554K | 0.03% | 254 |
|
|
2017
Q2 | $3.7M | Sell |
13,620
-805
| -6% | -$213K | 0.02% | 274 |
|
|
2017
Q1 | $3.94M | Sell |
14,425
-633
| -4% | -$179K | 0.02% | 272 |
|
|
2016
Q4 | $4.27M | Buy |
15,058
+1,005
| +7% | +$298K | 0.03% | 265 |
|
|
2016
Q3 | $4.4M | Buy |
14,053
+3,318
| +31% | +$983K | 0.03% | 265 |
|
|
2016
Q2 | $2.6M | Sell |
10,735
-78
| -0.7% | -$20.6K | 0.02% | 300 |
|
|
2016
Q1 | $2.81M | Buy |
10,813
+18
| +0.2% | +$4.75K | 0.02% | 291 |
|
|
2015
Q4 | $3.31M | Sell |
10,795
-1,311
| -11% | -$377K | 0.02% | 281 |
|
|
2015
Q3 | $3.53M | Sell |
12,106
-81
| -0.7% | -$26.7K | 0.03% | 283 |
|
|
2015
Q2 | $4.92M | Sell |
12,187
-556
| -4% | -$223K | 0.03% | 263 |
|
|
2015
Q1 | $5.38M | Sell |
12,743
-375
| -3% | -$148K | 0.04% | 259 |
|
|
2014
Q4 | $4.45M | Sell |
13,118
-1,425
| -10% | -$461K | 0.03% | 279 |
|
|
2014
Q3 | $4.81M | Sell |
14,543
-3,045
| -17% | -$1M | 0.03% | 273 |
|
|
2014
Q2 | $5.55M | Sell |
17,588
-908
| -5% | -$273K | 0.04% | 253 |
|
|
2014
Q1 | $5.66M | Sell |
18,496
-839
| -4% | -$266K | 0.04% | 249 |
|
|
2013
Q4 | $5.41M | Sell |
19,335
-72
| -0.4% | -$18.6K | 0.04% | 246 |
|
|
2013
Q3 | $4.67M | Sell |
19,407
-246,809
| -93% | -$55.2M | 0.03% | 260 |
|
|
2013
Q2 | $58.2M | Buy |
+266,216
| New | +$56.9M | 0.21% | 102 |
|
Other funds holding BIIB
KeyBank National Association's BIIB Position: Q2 2026 in Review
KeyBank National Association reduced its Biogen (BIIB) stake by 12% in Q2 2026, selling an estimated $203K and leaving 7,775 shares worth $1.68M. The position accounts for 0.01% of the portfolio, ranked #519.
KeyBank National Association first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $58.2M in Q2 2013. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- KeyBank National Association held 7,775 shares of Biogen worth $1.68M as of Q2 2026.
- KeyBank National Association sold 1,059 Biogen shares in Q2 2026, an estimated $203K.
- Biogen made up 0.01% of KeyBank National Association's portfolio in Q2 2026, its #519 holding.
- KeyBank National Association first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- KeyBank National Association's Biogen position peaked at $58.2M in Q2 2013.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.